Summary & Overview
CPT 0205U: Vita Risk® Test for AMD Zinc-Related Progression Risk
CPT code 0205U identifies the Vita Risk® Proprietary Laboratory Analysis by Arctic Medical Laboratories, a targeted diagnostic test that indicates whether patients with dry age–related macular degeneration (AMD) have an elevated risk of progressing to wet AMD when taking zinc supplements. This one-of-a-kind PLA code matters nationally because it links a specific laboratory proprietary test to clinical decision-making around supplementation and AMD progression risk, which can affect clinical management and payer coverage determinations for genetic or biomarker-guided care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical purpose and service setting, typical payer considerations, and what to expect in coverage discussions for PLA tests. The publication outlines benchmarks and policy context relevant to proprietary laboratory codes, summarizes how payers commonly approach PLA coverage and medical necessity for specialty diagnostics, and provides clinical context on AMD progression risk related to zinc supplementation.
This national summary is intended to orient clinical, coding, and policy stakeholders to the role of CPT code 0205U in diagnostic workflows, payer conversations, and lab service delivery for patients with dry AMD.
Billing Code Overview
CPT code 0205U is a Proprietary Laboratory Analyses (PLA) code that describes a single, manufacturer-specific laboratory test: the Vita Risk® test by Arctic Medical Laboratories. The test evaluates whether a patient has an increased risk of progressing from dry to wet age–related macular degeneration (AMD) if they take zinc supplements.
Service Type: Proprietary laboratory diagnostic test
Typical Site of Service: Clinical laboratory or specialty diagnostic laboratory; specimen collection may occur in an outpatient clinic or ophthalmology practice
Clinical & Coding Specifications
Clinical Context
A 72-year-old patient with intermediate dry age-related macular degeneration (AMD) presents to a retinal specialist for risk stratification prior to initiating or continuing oral zinc-containing supplementation. The clinician orders the Vita Risk® test (0205U) from Arctic Medical Laboratories to evaluate the patient’s genetic and biomarker profile associated with progression from dry (non-neovascular) to wet (neovascular) AMD when zinc supplements are used. Typical workflow: the retina clinic or ophthalmology practice collects a blood sample or buccal swab per the lab’s kit instructions during an outpatient visit; the specimen is shipped to the performing laboratory. Results return to the ordering clinician electronically and are reviewed in follow-up to inform counseling about supplement safety and monitoring frequency. Typical site of service: outpatient ophthalmology or retinal specialty clinic, ambulatory laboratory collection center, or home specimen collection arranged by the laboratory.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional (interpretation) component if the laboratory separates technical and professional reporting and the payer requires distinct reporting. |
TC | Technical component | Use when reporting only the technical component (laboratory processing) if billed separately by the performing laboratory. |
59 | Data not available in the input. | Data not available in the input. |
52 | Reduced services | Use when the laboratory test was partially performed or limited vs the full test as reported by the performing lab (apply per payer rules). |
53 | Discontinued procedure | Use if specimen collection or testing was started but discontinued for clinical or technical reasons. |
76 | Data not available in the input. | Data not available in the input. |
80 | Assistant surgeon | Use if an assistant surgeon is clinically involved in specimen collection in a surgical setting; rarely applicable for this outpatient lab test. |
62 | Two surgeons | Use if two surgeons of different specialties are involved in specimen acquisition during a procedure that included collection for this test. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist performing services in whole or in part | Use when an advanced practice provider orders and documents specimen collection and the payer requires the AS modifier. |
QK | Medical direction of two or more qualified individuals | Use when the ordering physician provides medical direction over multiple individuals involved in specimen acquisition or testing workflows per payer policy. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
208C00000X | Ophthalmology | Retinal specialists and general ophthalmologists commonly order the test for AMD management. |
207K00000X | Optometry | Optometrists in medical therapy roles may order or coordinate specimen collection and follow-up counseling. |
2080S0102X | Retina Specialist | Subspecialists in vitreoretinal disease managing AMD progression and treatment decisions. |
363A00000X | Clinical Laboratory Director | Laboratory medical directors oversee testing quality and result interpretation at the performing lab. |
207L00000X | Physician Assistant | Advanced practice providers involved in outpatient specimen collection and patient counseling. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
H35.31 | Nonexudative age-related macular degeneration (AMD) | Indicates dry AMD; primary clinical indication for risk assessment with the Vita Risk® test prior to zinc supplementation. |
H35.32 | Exudative age-related macular degeneration (AMD) | Relevant for baseline status; differentiates patients who already have wet AMD from those at risk of progression. |
H35.33 | Bilateral age-related macular degeneration | Used when AMD affects both eyes; may affect management decisions regarding supplements and monitoring. |
Z79.899 | Other long term (current) drug therapy | May be used to document ongoing supplement or medication therapy when assessing risk related to zinc use. |
Z01.00 | Encounter for examination of eyes and vision without abnormal findings | May be used for screening or routine ophthalmic follow-up visits when ordering risk stratification testing. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
0205U | Vita Risk® test (Proprietary Laboratory Analyses) — identifies increased risk of progression from dry to wet AMD with zinc supplementation | Primary PLA code describing the specific proprietary assay performed by Arctic Medical Laboratories. |
36415 | Collection of venous blood by venipuncture | Commonly performed immediately prior to sending a sample to the laboratory when blood is the required specimen for the Vita Risk® test. |
99000 | Handling and/or conveyance of specimen for transfer from the physician’s office to a laboratory | Used when the clinic bills for specimen collection handling or courier services per payer rules. |
G0008 | Data not available in the input. | Data not available in the input. |
86328 | Immunoassay for infectious agent antibody(ies) | Data not available in the input. |
Note: Where specific related codes were not provided in the input, common specimen collection and handling CPT codes are listed to reflect routine clinical workflow around a proprietary laboratory assay.